Metabolic Brain Disease

, Volume 33, Issue 3, pp 681–691 | Cite as

Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice

  • Amrita A. Chowdhury
  • Nitin B. Gawali
  • Renuka Munshi
  • Archana R. Juvekar
Original Article
  • 285 Downloads

Abstract

Neuroinflammation is said to play a pivotal role in the pathogenesis of neurodegenerative disorders such as Alzheimer’s disease (AD). Trigonelline (TRG) is a naturally occurring alkaloid, commonly isolated from fenugreek and coffee beans. In the present study, we investigated whether TRG exerts neuroprotective action against LPS mediated cognitive impairment. Mice pretreated with TRG (50 and 100 mg/kg po) were administered with LPS (250 μg/kg ip) for 7 days. Memory was assessed in the Morris water maze (MWM) and Y maze. LPS administration caused poor memory retention in MWM and Y maze paradigms, and resulted in marked oxidative stress as evidenced by decrease in superoxide dismutase (SOD), reduced glutathione (GSH) levels and increased lipid peroxidation in the hippocampus and cortex. Cholinergic involvement during neuroinflammation was evaluated by measuring levels of acetylcholinesterase (AChE) enzyme. TRG treatment at both the doses reversed LPS induced behavioral and memory disturbances, significantly decreased the oxidative stress and AChE levels in both the hippocampus and cortex. LPS administration also elevated the tumour necrosis factor (TNF-α) and interleukin −6 (IL-6) levels, whereas brain derived neurotrophic factor (BDNF) levels were significantly depleted. TRG pretreatment led to decreased TNF-α and IL-6 levels and caused a significant upregulation of BDNF levels. In conclusion, present study highlights the promising neuroprotective role of TRG against LPS mediated cognitive impairment which could be attributed to reduced oxidative stress, inhibition of proinflammatory cytokines and restoration of BDNF levels.

Keywords

Brain derived neurotrophic factor Oxidative stress Trigonelline Lipopolysaccharide Neuroinflammation 

Notes

Acknowledgements

This study has been funded by grants from University Grants Commission (UGC), India.

Compliance with ethical standards

Conflicts of interest

The authors declare that there are no conflicts of interest.

References

  1. Aldakinah AAA, Al-Shorbagy MY, Abdallah DM, El-Abhar HS (2017) Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway. J Pharm Pharmacol 69(7):856–864.  https://doi.org/10.1111/jphp.12713 CrossRefPubMedGoogle Scholar
  2. Antonisamy P, Arasu MV, Dhanasekaran M, Choi KC, Aravinthan A, Kim NS, Kang C-W, Kim J-H (2016) Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms. Food Funct 7(1):398–408.  https://doi.org/10.1039/C5FO00403A CrossRefPubMedGoogle Scholar
  3. Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse M, Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32(40):4825–4835.  https://doi.org/10.1038/onc.2012.493 CrossRefPubMedGoogle Scholar
  4. Association, A. s (2016) 2016 Alzheimer's disease facts and figures. Alzheimers Dement 12(4):459–509.  https://doi.org/10.1016/j.jalz.2016.03.001 CrossRefGoogle Scholar
  5. Badshah H, Ali T, Kim MO (2016) Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway. Sci Rep 6(1):24493.  https://doi.org/10.1038/srep24493 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Choi D-Y, Lee JW, Lin G, Lee YK, Lee YH, Choi IS, Han SB, Jung JK, Kim YH, Kim KH (2012) Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochem Int 60(1):68–77.  https://doi.org/10.1016/j.neuint.2011.11.005 CrossRefPubMedGoogle Scholar
  7. Chowdhury AA, Gawali NB, Bulani VD, Kothavade PS, Mestry SN, Deshpande PS, Juvekar AR (2017) In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in D-galactose induced cognitive impairment. Pharmacol Rep.  https://doi.org/10.1016/j.pharep.2017.09.006
  8. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature. Rev Neurosci 9(1):46–56.  https://doi.org/10.1038/nrn2297 CrossRefGoogle Scholar
  9. Deng X, Meili Li WA, He L, Lu D, Patrylo PR, Cai H, Luo X, Li Z, Yan X (2014) Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats. Adv Alzheimer Dis 3(2):78–93.  https://doi.org/10.4236/aad.2014.32009 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88–95.  https://doi.org/10.1016/0006-2952(61)90145-9 CrossRefPubMedGoogle Scholar
  11. García-Ayllón M-S, Small DH, Avila J, Sáez-Valero J (2011) Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid. Front Mol Neurosci 4.  https://doi.org/10.3389/fnmol.2011.00022
  12. Gaur V, Bodhankar SL, Mohan V, Thakurdesai PA (2013) Neurobehavioral assessment of hydroalcoholic extract of Trigonella Foenum-Graecum seeds in rodent models of Parkinson’s disease. Pharm Biol 51(5):550–557.  https://doi.org/10.3109/13880209.2012.747547 CrossRefPubMedGoogle Scholar
  13. Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G, Bertini R (2000) LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 12(8):1205–1210.  https://doi.org/10.1006/cyto.2000.0697 CrossRefPubMedGoogle Scholar
  14. Gong Q-H, Wang Q, Pan L-L, Liu X-H, Huang H, Zhu Y-Z (2010) Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol Biochem Behav 96(1):52–58.  https://doi.org/10.1016/j.pbb.2010.04.006 CrossRefPubMedGoogle Scholar
  15. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22(1):219–240.  https://doi.org/10.1146/annurev.neuro.22.1.219 CrossRefPubMedGoogle Scholar
  16. Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751–766PubMedGoogle Scholar
  17. Götz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nature. Rev Neurosci 9(7):532–544.  https://doi.org/10.1038/nrn2420 CrossRefGoogle Scholar
  18. Guan Z, Fang J (2006) Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun 20(1):64–71.  https://doi.org/10.1016/j.bbi.2005.04.005 CrossRefPubMedGoogle Scholar
  19. Hauss-Wegrzyniak B, Lukovic L, Bigaud M, Stoeckel M (1998) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 794(2):211–224.  https://doi.org/10.1016/S0006-8993(98)00227-3 CrossRefPubMedGoogle Scholar
  20. Helmy AA, Naseer MMA, El Shafie S, Nada MA (2012) Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Neurodegener Dis 9(2):81–86.  https://doi.org/10.1159/000329568 CrossRefPubMedGoogle Scholar
  21. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14(4):388–405.  https://doi.org/10.1016/S1474-4422(15)70016-5 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nature. Rev Neurosci 16(6):358–372.  https://doi.org/10.1038/nrn3880 CrossRefGoogle Scholar
  23. Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28(33):8354–8360.  https://doi.org/10.1523/JNEUROSCI.0616-08.2008 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57(6):846–851.  https://doi.org/10.1001/archneur.57.6.846 CrossRefPubMedGoogle Scholar
  25. Hong BN, Yi TH, Park R, Kim SY, Kang TH (2008) Coffee improves auditory neuropathy in diabetic mice. Neurosci Lett 441(3):302–306.  https://doi.org/10.1016/j.neulet.2008.06.049 CrossRefPubMedGoogle Scholar
  26. Hou Y, Xie G, Miao F, Ding L, Mou Y, Wang L, Su G, Chen G, Yang J, Wu C (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 54:92–102.  https://doi.org/10.1016/j.pnpbp.2014.03.015 CrossRefGoogle Scholar
  27. Ilavenil S, Arasu MV, Lee J-C, Kim DH, Roh SG, Park HS, Choi GJ, Mayakrishnan V, Choi KC (2014) Trigonelline attenuates the adipocyte differentiation and lipid accumulation in 3T3-L1 cells. Phytomedicine 21(5):758–765.  https://doi.org/10.1016/j.phymed.2013.11.007 CrossRefPubMedGoogle Scholar
  28. Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16(4):881–891.  https://doi.org/10.1016/S0896-6273(00)80108-7 CrossRefPubMedGoogle Scholar
  29. Ittner LM, Götz J (2011) Amyloid-β and tau—a toxic pas de deux in Alzheimer's disease. Nature. Rev Neurosci 12(2):67–72CrossRefGoogle Scholar
  30. Jang YJ, Kim J, Shim J, Kim C-Y, Jang J-H, Lee KW, Lee HJ (2013) Decaffeinated coffee prevents scopolamine-induced memory impairment in rats. Behav Brain Res 245:113–119.  https://doi.org/10.1016/j.bbr.2013.02.003 CrossRefPubMedGoogle Scholar
  31. Jiang T, Sun Q, Chen S (2016) Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol 147:1–19.  https://doi.org/10.1016/j.pneurobio.2016.07.005 CrossRefPubMedGoogle Scholar
  32. Joshi R, Garabadu D, Teja GR, Krishnamurthy S (2014) Silibinin ameliorates LPS-induced memory deficits in experimental animals. Neurobiol Learn Mem 116:117–131.  https://doi.org/10.1016/j.nlm.2014.09.006 CrossRefPubMedGoogle Scholar
  33. Kamble HV, Bodhankar SL (2013) Antihyperglycemic activity of trigonelline and sitagliptin in nicotinamide-streptozotocin induced diabetes in Wistar rats. Biomedicine & Aging Pathology 3(3):125–130.  https://doi.org/10.1016/j.biomag.2013.05.006 CrossRefGoogle Scholar
  34. Kirsten TB, Galvão MC, Reis-Silva TM, Queiroz-Hazarbassanov N, Bernardi MM (2015) Zinc prevents sickness behavior in duced by lipopolysaccharides after a stress challenge in rats. PLoS One 10(3):e0120263.  https://doi.org/10.1371/journal.pone.0120263 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25(39):8843–8853.  https://doi.org/10.1523/JNEUROSCI.2868-05.2005 CrossRefPubMedGoogle Scholar
  36. Koenigsknecht-Talboo J, Landreth GE (2005) Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25(36):8240–8249.  https://doi.org/10.1523/JNEUROSCI.1808-05.2005 CrossRefPubMedGoogle Scholar
  37. Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H, Heppner FL (2013) Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8(4):e60921.  https://doi.org/10.1371/journal.pone.0060921 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Ma M, Chen Y, He J, Zeng T, Wang J (2007) Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience 147(4):1059–1065.  https://doi.org/10.1016/j.neuroscience.2007.05.020 CrossRefPubMedGoogle Scholar
  39. Ma L, Zhang H, Liu N, Wang PQ et al (2016) TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration. Brain Res. Bull 121:192–200CrossRefPubMedGoogle Scholar
  40. Mayakrishnan T, Nakkala JR, Jeepipalli SPK, Raja K, Chandra VK, Mohan VK, Sadras SR (2014) Fenugreek seed extract and its phytocompounds-trigonelline and diosgenin arbitrate their hepatoprotective effects through attenuation of endoplasmic reticulum stress and oxidative stress in type 2 diabetic rats. Eur Food Res Technol 240(1):223–232CrossRefGoogle Scholar
  41. McCaulley ME, Grush KA (2015) Alzheimer’s disease: exploring the role of inflammation and implications for treatment. Int J Alzheimers dis. 2015. Article ID 515248Google Scholar
  42. Nandi A, Chatterjee I (1988) Assay of superoxide dismutase activity in animal tissues. J Biosci 13(3):305–315.  https://doi.org/10.1007/BF02712155 CrossRefGoogle Scholar
  43. Noworyta-Sokołowska K, Górska A, Gołembiowska K (2013) LPS-induced oxidative stress and inflammatory reaction in the rat striatum. Pharmacol Rep 65(4):863–869.  https://doi.org/10.1016/S1734-1140(13)71067-3 CrossRefPubMedGoogle Scholar
  44. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–335.  https://doi.org/10.1016/0003-2697(79)90738-3 CrossRefPubMedGoogle Scholar
  45. Panda S, Biswas S, Kar A (2013) Trigonelline isolated from fenugreek seed protects against isoproterenol-induced myocardial injury through down-regulation of Hsp27 and αB-crystallin. Nutrition 29(11):1395–1403.  https://doi.org/10.1016/j.nut.2013.05.006 CrossRefPubMedGoogle Scholar
  46. Patel NS, Paris D, Mathura V, Quadros AN, Crawford FC, Mullan MJ (2005) Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation 2(1):9.  https://doi.org/10.1186/1742-2094-2-9 CrossRefPubMedPubMedCentralGoogle Scholar
  47. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7(5):695–702.  https://doi.org/10.1016/0896-6273(91)90273-3 CrossRefPubMedGoogle Scholar
  48. Prince MJ (2015) World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, LondonGoogle Scholar
  49. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5):453–462.  https://doi.org/10.1002/glia.20467 CrossRefPubMedPubMedCentralGoogle Scholar
  50. Satheeshkumar N, Mukherjee PK, Bhadra S, Saha B (2010) Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine 17(3):292–295.  https://doi.org/10.1016/j.phymed.2009.06.006 CrossRefPubMedGoogle Scholar
  51. Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur. J. Med Chem 70:165–188Google Scholar
  52. Smith IK, Vierheller TL, Thorne CA (1988) Assay of glutathione reductase in crude tissue homogenates using 5, 5′-dithiobis (2-nitrobenzoic acid). Anal Biochem 175(2):408–413.  https://doi.org/10.1016/0003-2697(88)90564-7 CrossRefPubMedGoogle Scholar
  53. Tanila H (2017) The role of BDNF in Alzheimer's disease. Neurobiol Dis 97(Pt B):114–118CrossRefPubMedGoogle Scholar
  54. Tharaheswari M, Reddy NJ, Kumar R, Varshney K, Kannan M, Rani SS (2014) Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol Cell Biochem 396(1–2):161–174.  https://doi.org/10.1007/s11010-014-2152-x CrossRefPubMedGoogle Scholar
  55. Tohda C, Nakamura N, Komatsu K, Hattori M (1999) Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol Pharm Bull 22(7):679–682.  https://doi.org/10.1248/bpb.22.679 CrossRefPubMedGoogle Scholar
  56. Tohda C, Kuboyama T, Komatsu K (2005) Search for natural products related to regeneration of the neuronal network. Neurosignals 14(1–2):34–45.  https://doi.org/10.1159/000085384 CrossRefPubMedGoogle Scholar
  57. Wang W-Y, Tan M-S, Yu J-T, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med 3(10):136.  https://doi.org/10.3978/j.issn.2305-5839.2015.03.49 PubMedPubMedCentralGoogle Scholar
  58. Wei P, Liu Q, Li D, Zheng Q, Zhou J, Li J (2015) Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus. Neurosci Lett 604:161–166.  https://doi.org/10.1016/j.neulet.2015.08.008 CrossRefPubMedGoogle Scholar
  59. Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q (2017) Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a phase II multicenter randomised controlled trial. Age Ageing:1–7Google Scholar
  60. Yoshinari O, Takenake A, Igarashi K (2013) Trigonelline ameliorates oxidative stress in type 2 diabetic Goto-Kakizaki rats. J Med Food 16(1):34–41.  https://doi.org/10.1089/jmf.2012.2311 CrossRefPubMedGoogle Scholar
  61. Zhang D-F, Zhang F, Zhang J, Zhang R-M, Li R (2015) Protection effect of trigonelline on liver of rats with non-alcoholic fatty liver diseases. Asian Pac J. Trop Biomed 8(8):651–654Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  • Amrita A. Chowdhury
    • 1
  • Nitin B. Gawali
    • 1
  • Renuka Munshi
    • 2
  • Archana R. Juvekar
    • 1
  1. 1.Department of Pharmaceutical Sciences and Technology (DPST)Institute of Chemical Technology (ICT)MumbaiIndia
  2. 2.Department of Clinical Pharmacology, B. Y. L. Nair Charitable Hospital and Topiwala National Medical CollegeMumbaiIndia

Personalised recommendations